|
Jinn Wu, Ph.D. is the Founder and President of Xenobiotics Laboratories Inc. (XBL) in Princeton, New Jersey. XBL is a contract research organization that provides an extensive array of clinical and preclinical research services to the biotechnology and pharmaceutical industry.
Dr. Wu earned a Ph.D. in Natural Products and Medicinal Chemistry from Ohio State University and spent several years as a research scientist at FMC Corporation, before starting XBL. He is an adjunct professor at the University of Medicine and Dentistry of New Jersey and is a member of the American Association of Pharmaceutical Scientists (AAPS), the International Society for the Study of Xenobiotics (ISSX), the American Society of Pharmacognosy (ASP) and the American Chemical Society (ACS).
Dr. Wu serves on the Board of Directors of Enhance Biotech Incorporated and has served on the Board of Ardent Pharmaceuticals. Dr. Wu brings extensive biopharma business experience to the Board of Kinex Pharmaceuticals. | 